{"id":1326,"date":"2008-11-26T12:51:17","date_gmt":"2008-11-26T18:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=1326"},"modified":"2018-01-22T16:08:43","modified_gmt":"2018-01-22T22:08:43","slug":"1326","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/1326\/","title":{"rendered":"Not\u00edcias e notas de sa\u00fade animal de 26 de novembro de 2008"},"content":{"rendered":"

vers\u00e3o para impress\u00e3o<\/a><\/p>\n

*******************************************************************
\nBrakke Consulting's
\nNot\u00edcias e notas de sa\u00fade animal de 26 de novembro de 2008
\n<\/strong>Copyright \u00a9 Brakke Consulting, Inc.
\n 
\nEditor: Lynn Fondon, DVM, MBA
\n*******************************************************************
\nNAS NOTICIAS :
\n 
\nnot\u00edcias de ganhos<\/u>
\nJardim central e animal de estima\u00e7\u00e3o
\nEvialis
\n 
\noutras not\u00edcias<\/u>
\nAB Science
\nAlbion
\nalfarma
\nAscor Chimici
\nbiof\u00e1rmaco
\nBoehringer Ingelheim Vetmedica
\nBOMAC Vets Plus
\nDainippon Sumitomo Pharma
\nIDEXX
\nKing Pharmaceuticals
\nTerap\u00eautica Veterin\u00e1ria Moderna
\nNestl\u00e9 Purina
\nVetoquinol 
\n 
\n*******************************************************************
\n2008 CONTROLE DE PULGAS E MERCADOS DE HEARTWORM
\nO \u00daLTIMO DIA PARA O DESCONTO EARLY-BIRD \u00c9 NOVEMBRO. 26!
\n 
\nEntre em contato com a Dra. Lynn Fondon em lfondon@brakkeconsulting.com<\/a> ou 972-243-4033 para encomendar ou para mais informa\u00e7\u00f5es.
\n 
\nwww.BrakkeConsulting.com<\/a>
\n 
\n*******************************************************************
\nRELEASES DE RESULTADOS DA EMPRESA
\n 
\n> A Evialis reportou uma receita de EUR 304 milh\u00f5es ($439 milh\u00f5es) no primeiro trimestre do ano financeiro de 2008-2009 encerrado em 30 de setembro, um aumento de quase 64%. O aumento refletiu o alto pre\u00e7o das mat\u00e9rias-primas, bem como a contribui\u00e7\u00e3o dos neg\u00f3cios adquiridos. Em uma base compar\u00e1vel, a receita aumentou 26% em rela\u00e7\u00e3o ao ano anterior. (Farm\u00e1cia Animal)
\n 
\n> A Central Garden & Pet informou os resultados do quarto trimestre encerrado em 27 de setembro de 2008. As vendas l\u00edquidas para o segmento de produtos para animais de estima\u00e7\u00e3o foram $226 milh\u00f5es, um aumento de 2% em compara\u00e7\u00e3o com o per\u00edodo do ano anterior. (site da companhia)  
\n 
\n*******************************************************************
\nCOMUNICADOS DE NOT\u00cdCIAS DA EMPRESA
\n 
\n> A King Pharmaceuticals, Inc. e a Alpharma Inc. anunciaram que as duas empresas assinaram um acordo de fus\u00e3o definitivo segundo o qual a King adquirir\u00e1 todas as a\u00e7\u00f5es ordin\u00e1rias classe A em circula\u00e7\u00e3o da Alpharma por $37,00 por a\u00e7\u00e3o em dinheiro para um patrim\u00f4nio l\u00edquido total valor de aproximadamente $1,6 bilh\u00e3o. Os Conselhos de Administra\u00e7\u00e3o de ambas as empresas aprovaram a transa\u00e7\u00e3o por unanimidade. King observou que a divis\u00e3o de Sa\u00fade Animal da Alpharma aumentar\u00e1 a diversifica\u00e7\u00e3o dos neg\u00f3cios da King e dever\u00e1 fornecer fluxo de caixa est\u00e1vel para alimentar futuras iniciativas estrat\u00e9gicas. (PRNewswire)  
\n 
\n> A IDEXX Laboratories anunciou que vendeu sua franquia de Creme Antiinflamat\u00f3rio T\u00f3pico Surpass (1% diclofenaco s\u00f3dico) para a Boehringer Ingelheim Vetmedica, Inc. Os termos financeiros n\u00e3o foram divulgados. (site da companhia)
\n 
\n> A Vetoquinol anunciou que fechou acordo para adquirir a Ascor Chimici Srl, empresa italiana que fabrica e comercializa pr\u00e9-misturas medicamentosas e antibi\u00f3ticos para bovinos, su\u00ednos e aves, al\u00e9m de distribuir produtos para animais de companhia. A Ascor Chimici registrou vendas de 21 milh\u00f5es de euros ($30 milh\u00f5es) em 2007. Os termos financeiros n\u00e3o foram divulgados. (site da companhia)
\n 
\n> A Modern Veterinary Therapeutics anunciou a aprova\u00e7\u00e3o do Vetazine Cream pela FDA, um tratamento t\u00f3pico para dermatite al\u00e9rgica e eczema de ver\u00e3o em c\u00e3es. (comunicado de imprensa da empresa)  
\n 
\n> A Nestl\u00e9 Purina anunciou planos para construir um novo centro multimilion\u00e1rio de 84.000 p\u00e9s quadrados para exposi\u00e7\u00f5es de c\u00e3es e testes de obedi\u00eancia e agilidade. Espera-se que o Purina Event Center seja inaugurado no outono de 2010 em Purina Farms em Gray Summit, Missouri, a cerca de uma hora do centro de St. Louis. (St. Louis Business Journal)
\n 
\n> A BOMAC Vets Plus Inc. anunciou que firmou uma alian\u00e7a estrat\u00e9gica com a Albion Animal Nutrition. A BOMAC Vets Plus produzir\u00e1 o gel Replamin da Albion e os produtos da marca Pull Thru e cuidar\u00e1 dos componentes de vendas e marketing para essas marcas. A Albion continuar\u00e1 a fornecer suporte t\u00e9cnico para as linhas de produtos e ser\u00e1 uma fonte de informa\u00e7\u00f5es sobre a import\u00e2ncia dos minerais residuais. (alimentos)  
\n 
\n> A AB Science SA anunciou que a Comiss\u00e3o Europ\u00e9ia concedeu uma autoriza\u00e7\u00e3o de comercializa\u00e7\u00e3o para o principal produto veterin\u00e1rio da AB Science, masitinibe (Masivet), um inibidor de tirosina quinase que aumenta significativamente a sobrevida em c\u00e3es com mastocitomas irressec\u00e1veis. Separadamente, a empresa tamb\u00e9m formou recentemente uma divis\u00e3o nos Estados Unidos, a AB Science USA, com Albert Ahn, DVM, como presidente da divis\u00e3o nos Estados Unidos. O masitinibe est\u00e1 sob revis\u00e3o para aprova\u00e7\u00e3o na mesma indica\u00e7\u00e3o pelo FDA sob o nome comercial Kinavet. (PRWeb) 
\n 
\n> JAP\u00c3O A Dainippon Sumitomo Pharma anunciou o lan\u00e7amento japon\u00eas de Cartrophen Vet Injection (pentosan polissulfato de s\u00f3dio) para aliviar a dor e a claudica\u00e7\u00e3o associadas \u00e0 osteoartrite em c\u00e3es. O produto \u00e9 fabricado pela Biopharm Australia Pty. Ltd. (not\u00edcias da empresa)  
\n 
\n*******************************************************************
\nNOT\u00cdCIAS DE SA\u00daDE ANIMAL
\n 
\n> Reino Unido \u2013 L\u00edngua Azul O Departamento de Meio Ambiente, Alimentos e Assuntos Rurais do Reino Unido (DEFRA) anunciou a detec\u00e7\u00e3o do sorotipo 1 da l\u00edngua azul (BTV1) em cinco bovinos importados em uma propriedade em Lancashire, Reino Unido. Os animais s\u00e3o origin\u00e1rios da zona restrita BTV1 e 8 no sudoeste da Fran\u00e7a. Este \u00e9 o primeiro caso de infec\u00e7\u00e3o por BTV1 no Reino Unido; n\u00e3o h\u00e1 evid\u00eancias de que o BTV1 esteja circulando no Reino Unido e nenhuma zona de controle adicional foi declarada. (alimentos)
\n 
\n> EUA \u2013 REGRA DA CEFALOSPORINA REVOGADA A FDA revogou a ordem que pro\u00edbe o uso extra-r\u00f3tulo de medicamentos antimicrobianos cefalospor\u00ednicos em animais destinados \u00e0 produ\u00e7\u00e3o de alimentos. A ag\u00eancia disse que est\u00e1 tomando essa medida para que possa considerar plenamente os muitos coment\u00e1rios substantivos que recebeu sobre a ordem de proibi\u00e7\u00e3o. A ordem, que entraria em vigor em 30 de novembro, teria alterado 21 CFR 530.41 para listar as cefalosporinas como proibidas de uso extra-r\u00f3tulo em animais produtores de alimentos. (alimentos)
\n 
\n> CANAD\u00c1 \u2013 GM HOGS Um pesquisador da Universidade de Guelph, em Ont\u00e1rio, criou uma nova ra\u00e7a de porco \u2013 apelidada de enviropig \u2013 cujo sistema digestivo atualizado produz estrume mais limpo. O enviropig mant\u00e9m mais f\u00f3sforo dentro de sua barriga, reduzindo a concentra\u00e7\u00e3o no esterco em cerca de 60%, de acordo com o desenvolvedor. A FDA deve decidir em breve se o porco geneticamente modificado pode ser criado e vendido nos Estados Unidos. (O s\u00edtio do porco)
\n 
\n******************************************************************
\nPONTO DE VISTA DA BRAKKE CONSULTORIA
\n 
\nTodos n\u00f3s da Brakke Consulting desejamos a cada um de nossos assinantes e clientes um Feliz Dia de A\u00e7\u00e3o de Gra\u00e7as!
\n 
\nRon Brakke
\nJoel Adamson
\nKen Berkholtz
\nRay Collier
\nLynn Fondon
\nAtsuo Hata
\nJay Lockhart
\nJohn Mannhaupt
\nSusan Mannhaupt
\nChristine Merle
\nRichard Miles
\nJane Morgan
\nKevin Scott
\nJohn Volk
\n 
\n*******************************************************************
\nEste boletim eletr\u00f4nico \u00e9 propriedade exclusiva da Brakke Consulting, Inc.
\nQualquer uso do conte\u00fado deste documento deve ser aprovado e devidamente atribu\u00eddo \u00e0 Brakke Consulting, Inc.
\nPara obter mais informa\u00e7\u00f5es sobre os servi\u00e7os e estudos sindicados da Brakke Consulting, visite nosso website em www.brakkeconsulting.com<\/a>.
\n 
\nBrakke Consulting, Inc.
\n2735 Villa Creek, Su\u00edte 140
\nDallas, TX 75234 EUA<\/p>","protected":false},"excerpt":{"rendered":"

vers\u00e3o para impress\u00e3o ******************************************************************** Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 26 de novembro de 2008 Copyright \u00a9 Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************************************************ NAS NOT\u00cdCIAS: not\u00edcias sobre lucros Central Garden & Pet Evialis outras not\u00edcias AB Science Albion Alpharma Ascor Chimici Biopharm Boehringer Ingelheim Vetmedica BOMAC Vets Plus Dainippon Sumitomo Pharma IDEXX King Pharmaceuticals Modern Veterinary Therapeutics Nestle Purina Vetoquinol *********************************************************************** MERCADOS DE CONTROLE DE PULGAS E DIROFILARIO DOS EUA DE 2008 \u00daLTIMO DIA PARA DESCONTO DE INSCRI\u00c7\u00c3O ANTECIPADA \u00c9 26 DE NOVEMBRO! Entre em contato com o Dr. Lynn Fondon pelo e-mail lfondon@brakkeconsulting.com ou pelo telefone 972-243-4033 para fazer pedidos ou obter mais informa\u00e7\u00f5es. www.BrakkeConsulting.com ******************************************************************** DIVULGA\u00c7\u00d5ES DE LUCROS DA EMPRESA > A Evialis relatou uma receita de EUR 304 milh\u00f5es ($439 milh\u00f5es) no primeiro trimestre do ano fiscal de 2008-2009 encerrado em 30 de setembro, um aumento de quase 64%. O aumento refletiu o alto pre\u00e7o das mat\u00e9rias-primas, bem como a contribui\u00e7\u00e3o dos neg\u00f3cios adquiridos. Em uma base compar\u00e1vel, a receita aumentou 26% em rela\u00e7\u00e3o ao ano anterior. (Animal Pharm) > A Central Garden & Pet relatou os resultados do quarto trimestre encerrado em 27 de setembro de 2008. As vendas l\u00edquidas do segmento de produtos para animais de estima\u00e7\u00e3o foram de $226 milh\u00f5es, um aumento de 2% em compara\u00e7\u00e3o ao per\u00edodo do ano anterior. (site da empresa) ****************************************************************** COMUNICADOS \u00c0 IMPRENSA DA EMPRESA > A King Pharmaceuticals, Inc. e a Alpharma Inc. anunciaram que as duas empresas<\/p>\n

Ver postagem completa<\/a><\/div>\n

;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-1326","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"\nNews from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/1326\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"printer friendly version ******************************************************************* Brakke Consulting’s Animal Health News & Notes for November 26, 2008 Copyright © Brakke Consulting, Inc.   Editor: Lynn Fondon, DVM, MBA ******************************************************************* IN THE NEWS :   earnings news Central Garden & Pet Evialis   other news AB Science Albion Alpharma Ascor Chimici Biopharm Boehringer Ingelheim Vetmedica BOMAC Vets Plus Dainippon Sumitomo Pharma IDEXX King Pharmaceuticals Modern Veterinary Therapeutics Nestle Purina Vetoquinol    ******************************************************************* 2008 US FLEA CONTROL & HEARTWORM MARKETS LAST DAY FOR EARLY-BIRD DISCOUNT IS NOV. 26!   Contact Dr. Lynn Fondon at lfondon@brakkeconsulting.com or 972-243-4033 to order or for more information.   www.BrakkeConsulting.com   ******************************************************************* COMPANY EARNINGS RELEASES   > Evialis has reported revenue of EUR 304 million ($439 million) for the first quarter of the 2008-2009 financial year ended September 30, an increase of nearly 64%. The increase reflected the high price of raw materials as well as the contribution of acquired businesses. On a like-for-like basis, revenue increased 26% over the previous year. (Animal Pharm)   > Central Garden & Pet reported results for the fourth quarter ended September 27, 2008. Net sales for the Pet Products segment were $226 million, an increase of 2% compared to the year-ago period.  (company website)     ******************************************************************* COMPANY NEWS RELEASES   > King Pharmaceuticals, Inc. and Alpharma Inc. announced that the two companiesView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/1326\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2008-11-26T18:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-01-22T22:08:43+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/1326\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/1326\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News & Notes for November 26, 2008\",\"datePublished\":\"2008-11-26T18:51:17+00:00\",\"dateModified\":\"2018-01-22T22:08:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/1326\/\"},\"wordCount\":1002,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/1326\/\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/1326\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\"},\"datePublished\":\"2008-11-26T18:51:17+00:00\",\"dateModified\":\"2018-01-22T22:08:43+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/1326\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/pt\/1326\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/1326\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News & Notes for November 26, 2008\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/1326\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"printer friendly version ******************************************************************* Brakke Consulting’s Animal Health News & Notes for November 26, 2008 Copyright © Brakke Consulting, Inc.   Editor: Lynn Fondon, DVM, MBA ******************************************************************* IN THE NEWS :   earnings news Central Garden & Pet Evialis   other news AB Science Albion Alpharma Ascor Chimici Biopharm Boehringer Ingelheim Vetmedica BOMAC Vets Plus Dainippon Sumitomo Pharma IDEXX King Pharmaceuticals Modern Veterinary Therapeutics Nestle Purina Vetoquinol    ******************************************************************* 2008 US FLEA CONTROL & HEARTWORM MARKETS LAST DAY FOR EARLY-BIRD DISCOUNT IS NOV. 26!   Contact Dr. Lynn Fondon at lfondon@brakkeconsulting.com or 972-243-4033 to order or for more information.   www.BrakkeConsulting.com   ******************************************************************* COMPANY EARNINGS RELEASES   > Evialis has reported revenue of EUR 304 million ($439 million) for the first quarter of the 2008-2009 financial year ended September 30, an increase of nearly 64%. The increase reflected the high price of raw materials as well as the contribution of acquired businesses. On a like-for-like basis, revenue increased 26% over the previous year. (Animal Pharm)   > Central Garden & Pet reported results for the fourth quarter ended September 27, 2008. Net sales for the Pet Products segment were $226 million, an increase of 2% compared to the year-ago period.  (company website)     ******************************************************************* COMPANY NEWS RELEASES   > King Pharmaceuticals, Inc. and Alpharma Inc. announced that the two companiesView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/1326\/","og_site_name":"Brakke Consulting Website","article_published_time":"2008-11-26T18:51:17+00:00","article_modified_time":"2018-01-22T22:08:43+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/pt\/1326\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/pt\/1326\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News & Notes for November 26, 2008","datePublished":"2008-11-26T18:51:17+00:00","dateModified":"2018-01-22T22:08:43+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/pt\/1326\/"},"wordCount":1002,"articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/pt\/1326\/","url":"https:\/\/brakkeconsulting.com\/pt\/1326\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#website"},"datePublished":"2008-11-26T18:51:17+00:00","dateModified":"2018-01-22T22:08:43+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/pt\/1326\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/pt\/1326\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/pt\/1326\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News & Notes for November 26, 2008"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/zh\/#website","url":"https:\/\/brakkeconsulting.com\/zh\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/1326","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=1326"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/1326\/revisions"}],"predecessor-version":[{"id":1339,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/1326\/revisions\/1339"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=1326"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=1326"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=1326"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}